Lewnard et al. data (JAN 2022) reconciles US data with European and Nordic data: "Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California"
by Paul Alexander
Zero cases with Omicron variant infection received mechanical ventilation, as compared to 11 cases with Delta variant infections throughout the period of follow-up (two-sided p<0.001)
This Kaiser Permanente Southern California healthcare system study from November 30, 2021 to January 1, 2022, really is the nail in the coffin for OMICRON. This US California study reconciles with the European/Nordic data that COVID is over and Omicron is the off-ramp exit strategy.
I do not wish to be too long here but this recent January 2022 study is a welcomed one as shows the mild nature of Omicron relative to Delta (California) and shows the clinical outcomes in those infected with Omicron.
A key statement is this: “Zero cases with Omicron variant infection received mechanical ventilation, as compared to 11 cases with Delta variant infections throughout the period of follow-up (two-sided p<0.001).” The summary conclusion is: “During a period with mixed Delta and Omicron variant circulation, SARS-CoV-2 infections with presumed Omicron variant infection were associated with substantially reduced risk of severe clinical endpoints and shorter durations of hospital stay.”
Hospital admissions/1,000 cases: Delta, 12.7; Omicron, 3.5.
ICU admissions/1,000 cases: Delta, 1.4; Omicron, 0.1.
Ventilator use/1,000 cases: Delta, 0.6; Omicron, 0.
Deaths/1,000 cases: Delta, 0.8; Omicron, <0.1.
Days in hospital: Delta, 4.9; Omicron, 1.5.
Mary Beth Pfeiffer adds further:
“The study, by researchers at UC-Berkeley and Kaiser Permanente, suggests, as do others, that Omicron may be the death knell of the pandemic. But, buried deep within its piles of data, it also calls into question the utility of the vaccines themselves.”
https://trialsitenews.com/the-rise-of-omicron-is-the-fall-of-vaccines/
Unless one sells vaccines for a living, the overall numbers for the covid-19 variant Omicron will seem wildly encouraging.
Take a California study of 53,000 Omicron and 17,000 Delta cases from November 30, 2021, to January 1, 2022. In every way, Omicron patients did far better—a quarter the hospitalizations of Delta, miniscule admissions to ICU, no ventilation whatever, and a death rate of less than one-tenth of one percent.
The study, by researchers at UC-Berkeley and Kaiser Permanente, suggests, as do others, that Omicron may be the death knell of the pandemic. But, buried deep within its piles of data, it also calls into question the utility of the vaccines themselves.